Stonepine Capital Management, LLC Adicet Bio, Inc. Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
A detailed history of Stonepine Capital Management, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 700,000 shares of ACET stock, worth $693,000. This represents 0.54% of its overall portfolio holdings.
Number of Shares
700,000
Previous 609,446
14.86%
Holding current value
$693,000
Previous $878 Million
23.27%
% of portfolio
0.54%
Previous 0.55%
Shares
3 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59MCall Options Held
7.3KPut Options Held
39.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$11.3 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$8.06 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$7.47 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.17 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $39.6M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...